Taking your Genome to the Bank
By Harry Glorikian,
Genetic Engineering & Biotechnology News
| 12. 15. 2014
What’s more valuable than your money, equally vulnerable, and unique to you? Answer: Your genome. And just like your money, your genome should be stored securely as possible and those institutions that store your genome should be regulated on how they store it, use it, and potentially share it.
As medical science advances, it’s going to be increasingly important for people to be able to control and manage access to their personal genomes. To make this possible, we need to establish a formal, well-regulated system of genome banking. Just as the government regulates the banks that hold our money, we must also have it or an equivalent group/system to govern how institutions manage our genomic data. Because it is only by guaranteeing the security and use of that information that we will be able to exploit the full potential of the growing pool of genomic data for the betterment of the individual and for mankind.
Everyone’s genomic data, after all, is potentially life saving and life changing. We’ve long known that each of us has a unique string of three...
Related Articles
By Alondra Nelson, Science | 09.11.2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use...
By Emma McDonald Kennedy
| 09.25.2025
In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.
The response to the...
By Julie Métraux, Mother Jones | 09.23.2025
By Natalie Ram, Anya E. R. Prince, Jessica L. Roberts, Dov Fox, and Kayte Spector-Bagdady, Science | 09.11.2025
After declaring bankruptcy in March 2025, direct-to-consumer (DTC) genetic testing company 23andMe sold the data of more than 15 million people around the world to TTAM Research Institute, a nonprofit organization created by 23andMe’s founder and long-time CEO. 23andMe’s customers...